B. Baran Et Al. , "Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients," CLINICAL MEDICINE INSIGHTS: ONCOLOGY , vol.17, pp.1-8, 2023
Baran, B. Et Al. 2023. Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients. CLINICAL MEDICINE INSIGHTS: ONCOLOGY , vol.17 , 1-8.
Baran, B., Sanlav, G., Kizmazoglu, D., Ozsengezer, S. K., Aktas, S., Altun, Z., ... Olgun, N.(2023). Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients. CLINICAL MEDICINE INSIGHTS: ONCOLOGY , vol.17, 1-8.
Baran, BURÇİN Et Al. "Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients," CLINICAL MEDICINE INSIGHTS: ONCOLOGY , vol.17, 1-8, 2023
Baran, BURÇİN Et Al. "Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients." CLINICAL MEDICINE INSIGHTS: ONCOLOGY , vol.17, pp.1-8, 2023
Baran, B. Et Al. (2023) . "Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients." CLINICAL MEDICINE INSIGHTS: ONCOLOGY , vol.17, pp.1-8.
@article{article, author={BURÇİN BARAN Et Al. }, title={Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients}, journal={CLINICAL MEDICINE INSIGHTS: ONCOLOGY}, year=2023, pages={1-8} }